Side effects of antineoplastic and immunomodulating medications reported by European consumers

OBJECTIVE: To characterize adverse drug reactions (ADRs) reported by European (EU) consumer for antineoplastic and immunomodulating medications. METHODS: ADRs reported by consumers of antineoplastic and immunomodulating medications (anatomical therapeutic chemical [ATC]) group L from 2007 to 2011 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Aagaard, Lise, Hansen, Ebba Holme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076892/
https://www.ncbi.nlm.nih.gov/pubmed/24991604
http://dx.doi.org/10.4103/2279-042X.114091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076892/
https://www.ncbi.nlm.nih.gov/pubmed/24991604
http://dx.doi.org/10.4103/2279-042X.114091

Ejemplares similares